SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-22-052966
Filing Date
2022-04-29
Accepted
2022-04-29 09:08:59
Documents
2
Group Members
HAN 2020 GRAT

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2213787d1_sc13d.htm SC 13D 49983
2 EXHIBIT 99.1 tm2213787d1_ex99-1.htm EX-99.1 6916
  Complete submission text file 0001104659-22-052966.txt   58237
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Subject) CIK: 0001818838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92270 | Film No.: 22870695
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10179 HUENNEKENS STREET SUITE 103 SAN DIEGO, CA 92121
Business Address
Luo Peter (Filed by) CIK: 0001907614 (see all company filings)

Type: SC 13D